DIALYSIS 392813
A dialysis facility in PA. It ran an operating surplus of 4.3% in FY21 on $2.2M of operating revenue. Operating margin declined from 17.1% in FY20 to 4.3% in FY21.
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gatedRatios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio computes only when every input is reported in the filing (otherwise its cell states which input is Not reported in source); a year whose balance sheet does not reconcile is labeled, and its derived ratios read Astrelis calculation unavailable. Not audited by Astrelis.
| Line item | FY20 | FY21 |
|---|---|---|
| Patient revenue | 2,966 | 2,234 |
| Total operating revenue | 2,966 | 2,234 |
| Total operating expenses | 2,458 | 2,139 |
| Operating income | 508 | 95 |
| Operating margin % | +17.1% | +4.3% |
| Other non-operating, net | (144) | (37) |
| Net income | 364 | 58 |
| Net income % | +12.9% | +2.6% |
Trajectory
State context
4.3% operating margin in FY21.
Operating margin declined 12.9 points vs FY20 — the briefing traces why, line by line.
Reserve The Board Briefing →The Board Briefing
The record's final filed years, benchmarked against the peer pools of their own era and labeled so on every exhibit.